News

India cancels trade talks after Europe bans 700 generic drugs

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4387 (Published 12 August 2015) Cite this as: BMJ 2015;351:h4387
  1. Vidya Krishnan
  1. 1New Delhi

India’s government has cancelled a meeting with the European Union’s chief trade negotiator, due later this month, after the EU imposed an import ban on 700 generic drugs made by the company GVK Biosciences, which provides clinical trial services to many manufacturers of generic drugs across the country. The move is being seen as a serious blow to the proposed free trade agreement between the EU and India.

Negotiations over the agreement were scheduled to begin again at the end of the month after a two year break, with a meeting planned for 28 August between India’s chief trade negotiator, J S Deepak, and his EU counterpart, Ignacio Garcia Bercero.

However, the meeting was abruptly cancelled, and the Indian commerce ministry said in a written statement that it was “disappointed and concerned by …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe